Concentric Medical Merci
This article was originally published in The Gray Sheet
Executive Summary
Embolism retrieval system achieved cerebral revascularization in 51% of patients in the 81-patient, Phase I MERCI trial (41/81). The success rate, based on immediate post-procedure angiography, is a more accurate figure than the previously reported 81% rate that was based on 27 patients monitored with CT 24 hours post-procedure, according to the company (1"The Gray Sheet" Jan. 5, 2004, p. 7)...
You may also be interested in...
Merci Clot Retrieval Catheter Data Show 47% Event-Free Revascularization
Concentric Medical's Merci Retriever embolic retrieval system 510(k) data show a 38% mortality rate in stroke patients versus 27% in the placebo group
Concentric Medical’s Merci Cerebral Clot Remover Set For February Panel
Concentric Medical will present neurological function data for its Merci embolic retrieval system to FDA's Neurological Devices Advisory Panel Feb. 23
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.